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general practice
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Jan Mulder, Henk J M van den Hoogen, Guy E H M Rutten and Chris van Weel
Introduction
THE treatment of type 2 diabetes mellitus requires coun-selling on lifestyle modifications and dietary advice.
Consultation with a registered dietician is advised in most
guidelines for type 2 diabetes.1-2 The recommended dietary
advice should be tailored to patients’ individual needs and
aims. Diet therapy aims to reduce risk factors such as being
overweight and dyslipidemia. To achieve these aims, (mod-
est) weight loss by reducing total energy intake and the pro-
portion of total fat (<30% of energy intake), as well as a
reduction of saturated fat intake (<10% of energy intake) and
cholesterol intake (<300 mg/day), are strongly recom-
mended. Moreover, minimising trans-unsaturated fatty acid
intake and a modest intake of polyunsaturated fat (~10% of
energy intake) are advised (Box 1).1
Although these guidelines are based on solid evidence
from mostly experimental studies, they do not take into
account the normal dietary habits of the general population.
This might be partly because little is known about the fat
consumed by recently diagnosed patients with type 2 dia-
betes in general practice, or about alterations in dietary
habits after diagnosis and treatment. In the United Kingdom
(UK) prospective diabetes study, the intake of total fat in a
sample of 65 patients, both at baseline (38.2% of energy
intake) and after 3 years (36.9% of energy intake), was higher
than the recommended 30–35% of energy intake.3 Data from
a Dutch cross-sectional study showed no significant differ-
ences between diabetic and non-diabetic subjects regarding
total energy intake or the consumption of total, saturated or
polyunsaturated fats.4
The need for sensible treatment targets, which are root-
ed in the population for which they are aimed, has been
discussed before in relation to type 2 diabetes. So far, tar-
gets for the treatment of type 2 diabetes do not account
for what is feasible for patients to achieve in normal daily
life.5 We therefore investigated the fat consumption of
patients with newly diagnosed type 2 diabetes in general
practice.
The development of type 2 diabetes is associated with
unfavourable eating habits, such as high consumption of
total and saturated fat.6-8 We expected that the amount of
energy, and the amount and type of dietary fat consumed
by patients newly diagnosed with type 2 diabetes would
be unfavourable when compared with the intake of the
general population. Confirmation of this hypothesis would
support the above mentioned advice to refer all newly
diagnosed patients with type 2 diabetes to a dietician.
We conducted our study with the following research
questions: 
F A van de Laar, MD, general practitioner; E H van de Lisdonk, MD, PhD,
senior lecturer in general practice; P L B J Lucassen, MD, PhD, general
practitioner; J M H Tigchelaar, MD, general practitioner; 
J Mulder, BE, statistician; H J M van den Hoogen, statistician; 
C van Weel, MD, PhD, professor of general practice; University Medical
Centre Nijmegen, Department of General Practice, Nijmegen. S
Meyboom, RD, research dietician and nutritionist, Wageningen
University, Division of Human Nutrition, Wageningen. 
G E H M Rutten, MD, PhD, professor of general practice, Julius Centre for
Health Sciences and Primary Care, Utrecht, The Netherlands.
Address for correspondence
Floris van de Laar, UMC Nijmegen, Department of General Practice,
229 HAG, PO Box 9101, 6500 HB Nijmegen, The Netherlands.
E-mail: f.vandelaar@ hag.umcn.nl
Submitted: 17 July 2003; Editor’s response: 30 September 2003; 
final acceptance: 9 December 2003.
©British Journal of General Practice, 2004, 54, 177-182.
SUMMARY
Background: Although treatment targets for the consumption of
dietary fat in patients with type 2 diabetes mellitus are well
accepted, little is known about the actual fat consumption by newly
diagnosed patients or the dietary adjustments that they make in the
following years.
Aims: To measure fat intake in patients with type 2 diabetes in
general practice at diagnosis, shortly after dietary consultation, and
after 4 years.
Design of study: A prospective cohort study. 
Setting: Thirty-three general practices in The Netherlands.
Method: One hundred and forty-four patients with newly diagnosed
type 2 diabetes were referred to a dietician, and fat consumption (the
main outcome measure) was assessed with a 104-item food
frequency questionnaire at diagnosis, 8 weeks following diagnosis,
and after 4 years. Reference values for fat consumption were
obtained from an age-matched sample of a population-based survey.
Results: At diagnosis, total energy intake was 10.6 MJ/day and
cholesterol intake was 300 mg/day. Total fat consumption was
40.9% of energy intake, with saturated fatty acids 15.0%,
monounsaturated fatty acids 14.3%, and polyunsaturated fatty
acids 9.2% of energy intake. All levels, except for polyunsaturated
fatty acids, were significantly unfavourable compared with those for
the general population. After 8 weeks, consumption of saturated
fatty acids had decreased to a lower level than in the general
population and all other levels measured were similar to those for
the general population. After 4 years there was a slight increase in
the consumption of total fat and monounsaturated fatty acids, but
cholesterol and saturated fatty acid consumption had decreased
further. 
Conclusions: Patients with newly diagnosed type 2 diabetes have an
unfavourable fat consumption at diagnosis. They adapt to a more
desirable consumption shortly after diagnosis, and this improved
dietary behaviour is sustained for 4 years. Recommendations
regarding consumption of total and saturated fat are, in contrast to
those for cholesterol, not met by patients in general practice. 
Keywords: cohort studies; diabetes mellitus type 2; dietary fats;
diet, diabetic; family practice; food habits. 
 What is the fat consumption of patients with newly 
diagnosed type 2 diabetes in Dutch general practice
compared with reference values for the general 
population? 
 What are the alterations in fat consumption 8 weeks
after the initial diagnosis and referral to a dietician,
according to the Dutch guidelines for treatment of type
2 diabetes?2
 What is the fat consumption after 4 years of follow-up
compared with initial consumption in these patients?
Method
This study was designed as a prospective cohort study.
Reference values for the general population were obtained
from the Dutch national food consumption survey (DNFCS)
1998.9
Patients and practices 
Forty-six general practitioners (GPs), working in 33 general
practices throughout The Netherlands, included patients
with newly diagnosed type 2 diabetes aged between 40
and 70 years in the study. Diabetes mellitus was defined
according to the criteria established by the World Health
Organization:10 patients were eligible for the study when
they had symptoms suggestive of diabetes mellitus and a
fasting blood glucose ³6.7 mmol/l and <20.0 mmol/l. In
patients with asymptomatic newly diagnosed diabetes, the
fasting blood glucose had to be ³6.7 mmol/l on two or more
occasions.
Treatment
In accordance with the Dutch guidelines for the treatment of
type 2 diabetes mellitus,2 all included patients were referred
to a registered dietician. Dietary intervention consisted of
two consultation sessions within a 4-week period, in which
patients received dietary advice concerning all aspects of
medical nutritional therapy for diabetes, tailored to their indi-
vidual needs. The dieticians were informed about baseline
fat consumption in all patients. Otherwise, the dieticians did
not receive extra training or use special protocols. Patients
who still had a fasting blood glucose ³6.7 mmol/l after
8 weeks were eligible for oral antidiabetic therapy. These
patients were asked to participate in a 30-week randomised
controlled trial comparing acarbose with tolbutamide.11
After the 30-week period, all patients received usual care
from their GP.
Measurements
Measurements took place at diagnosis, then after 8 weeks,
and after 4 years. The consumption of dietary fat was mea-
sured using a 104-item food frequency questionnaire, in
which the past month was used as the reference period.12,13
This questionnaire was filled out by the patient and checked
for errors by the investigator. Values for total energy per day
(MJ/day), total fat (% of energy intake), saturated fatty acids
(% of energy intake), monounsaturated fatty acids (% of
energy intake), polyunsaturated fatty acids (% of energy
intake) and cholesterol (mg/day) were calculated using a
computer program (VET Expres 1.02, BaS Nutrition Software,
The Netherlands) designed especially for the questionnaire.
For the 4 years measurement, an updated version of the
questionnaire was used (Wageningen University, The
Netherlands, unpublished, 1997), including an updated
calculation program (Komeet 3.0, BaS Nutrition Software,
The Netherlands). 
Body weight and height were measured without shoes
and with light clothing. Data on medical history, comorbidity
and use of medication were obtained from the patients’
records by their GPs. Information regarding any additional
visits to a dietician or the use of other sources for dietary
information were recorded with the help of a short question-
naire. At the 4 years follow-up, GPs made the same assess-
ment of medical history and comorbidity. Furthermore, GPs
provided information about the use of antidiabetic and cho-
lesterol-lowering medication during the interval. Central lab-
oratories (Andreas Hospital, Amsterdam for baseline and
short-term, Canisius Wilhelmina Hospital, Nijmegen for
4 years measurements) used standard techniques and ref-
erence ranges to measure glycosylated haemoglobin
(HbA1c) and lipids. Glucose measurements were per-
formed locally using a calibrated glucose analyser.
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HOW THIS FITS IN
What do we know?
Advice on fat consumption is considered 
to be an important issue for the treatment of 
patients with type 2 diabetes, but the actual 
fat consumption of these patients in general practice is not
known. Nor is it known to what extent patients adjust their diets
after diagnosis while receiving usual care by their general
practitioner. 
What does this paper add?
This study showed that patients with type 2 diabetes have an
unfavourable fat consumption. However, shortly after diagnosis
and dietary counselling, patients fat consumption improves
significantly. These improvements are maintained 4 years after
diagnosis.
Optimisation of fat consumption is an essential part of the
dietary treatment of patients with type 2 diabetes mellitus. 
In general, the recommendations are similar to those of the
general population aiming at a reduction of the consumption of
saturated fatty acids and cholesterol. The main sources of 
saturated fatty acids in The Netherlands are meat, spreads,
and dairy products. The total amount should be reduced or
replaced by poly- or monounsaturated fatty acids. To achieve
this, meat from pork or beef should be replaced by poultry,
game or fish, which contain a lot of polyunsaturated fatty acids.
Olive oil is rich in monounsaturated fatty acids, therefore it is
recommended that olive oil is used instead of butter for frying.
Cholesterol is consumed almost exclusively from egg yolk so
egg consumption (or products that contain egg yolk) should
be minimised.
Box 1. Dietary recommendations for patients with type 2 diabetes in
The Netherlands.
Reference values
Data from the DNFCS 1998 were used to serve as reference
values for fat intake by the general population. The DNFCS
was a cross-sectional study of a representative sample of the
Dutch population, comprising 6250 subjects (aged
1–97 years) using a 2-day dietary record method. To match
these with the cohort of patients with newly diagnosed dia-
betes, we used the proportion of subjects aged 40–70 years
(n = 2296).
Statistical analysis
Results are given as mean ± standard deviation (SD). For
comparison between groups (i.e., missing versus non-miss-
ing, male versus female), Student’s two-sample t-tests
were performed. For comparison of results between subse-
quent measurements, Student’s one-sample test was used.
Additionally, a repeated measure analysis was performed to
assess an overall time effect. In order to correct for multiple
testing, a was divided by the number of tests used.
Therefore, for the t-tests P<0.0024 and for the repeated
measure analysis P<0.0072 was considered significant.
Ethics approval
This study was performed in accordance with the declara-
tion of Helsinki. The protocol for the 8-week study was
approved by the Central Medical Committee for Studies in
General Practice. The Local Ethics Committee of the
University Medical Centre, Nijmegen approved the protocol
for the 4-year study. All patients gave their informed consent.
Results
The GPs included 144 patients with newly diagnosed type 2
diabetes in the study. Baseline measurements were per-
formed on all 144 patients, the 8-week measurements were
performed on 110 of the 144 patients, and 106 patients par-
ticipated in the long-term follow-up (4-year measurements)
after a mean of 3.9 years (SD = 1.0) (Figure 1). The baseline
characteristics of these 144 patients are displayed in Table 1.
With respect to blood glucose and lipid profile, the study
population was representative for patients newly diagnosed
with type 2 diabetes.14 The baseline results for patients who
did not participate in the 8-week or 4-year evaluation did not
differ significantly from results of the patients whose mea-
surements were not missing (data not shown). 
Fat consumption
Table 2 shows the mean (SD) values for energy intake and
fat consumption for newly diagnosed patients with type 2
diabetes at diagnosis, after 8 weeks, and after 4 years.
Compared with reference figures for the general population,
patients had a higher intake of energy and higher fat con-
sumption. The mean changes for the three possible intervals
are shown in Table 3. At the 8-week follow-up, we found a
decrease in total energy intake, total fat, saturated fatty
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Table 1. Baseline characteristics of 144 newly diagnosed patients
with type 2 diabetes in general practice. 
n Mean SD
Male/female 69/75
Age (years) 144 57.8 8.3
Body mass index (kg/m2) 134 29.5 5.2
Fasting blood glucose 
(mmol/l) 144 10.5a 6.7–19.6b
HbA1c (%) 131 9.0 2.6
Diastolic blood pressure 
(mm/Hg) 134 86 10
Systolic blood pressure 
(mm/Hg) 134 145 20
Total cholesterol (mmol/l) 130 6.2 1.1
LDL cholesterol (mmol/l) 125 3.9 1.0
HDL cholesterol (mmol/l) 126 1.1 0.3
Triglycerides (mmol/l) 131 2.7 1.5
aMedian. bRange. HbA1c = glycosylated haemoglobin; HDL = high-
density lipoprotein; LDL = low-density lipoprotein; SD = standard
deviation.
Dietary treatment
Newly diagnosed
patients with type 2
diabetes mellitus in
general practice
(1995–1998)
Diagnosis 
assessment 
(n = 144)
8 weeks 
assessment
(n = 110)
4 years assessment
(2000–2001) 
(n = 106)
Lost to 8 weeks
assessment 
(n = 34)
No 4 years 
assessment 
(n = 38)
Lost to 4 years
assessment 
(n = 24): 
16 refused, 5 died,
1 not suitable
according to GP, 
2 unknown
Lost to 4 years
assessment 
(n = 14): 
5 refused, 3 died, 
4 moved, 
1 GP refused to
cooperate, 
1 questionnaire
illegible
Lost to 8 weeks but 
recovered for 
4 years assessment
(n = 20) 
Figure 1. Study flow diagram.
acids, and monounsaturated fatty acids. Polyunsaturated
fatty acids and the relative cholesterol intake (mg/MJ) did
not change significantly. At the 4-year follow-up, consump-
tion of total fat and monounsaturated fatty acids increased
significantly compared to 8 weeks, but remained significant-
ly lower than the baseline. Consumption of cholesterol
decreased significantly compared to baseline and 8 weeks.
Other values did not differ significantly from the 8 weeks
measurements. The repeated measure analysis showed
similar results, with the exception that the difference in con-
sumption of total fat between 8 weeks and 4 years was not
significant. Male and female patients showed similar fat con-
sumption at baseline, except for energy and cholesterol
intake, which was higher in men. Women showed a more
profound decrease in the consumption of total fat, monoun-
saturated fatty acids, and saturated fatty acids in both the
8 weeks and 4 years measurements (data not shown).
When stratified for body weight (body mass index [BMI]
<25, ³25 and £30, >30 kg/m2), results were similar. In both
our study at all three time points, and in the reference figures
for the general population, the people with BMI >30 kg/m2
reported the lowest energy intake (data not shown).
Table 4 reports the percentage of patients that met the
guidelines for fat consumption. The percentage of patients
that met the guideline regarding saturated fatty acids (10%
of energy intake) increased from 7.6% at baseline to 27.4%
at the 4 years measurement. Similarly, the percentage of
patients that consumed less than 7% of energy intake by
way of saturated fatty acids increased from 0.7 to 9.4%.
Plasma lipids, glycaemic control and body weight
After 8 weeks and two consultations with a dietician, 25.7% of
the patients had a fasting blood glucose <6.7 mmol/l. HbA1c
had decreased from 9.0 to 7.8%, all plasma lipid values,
except for HDL-cholesterol and triglycerids, had improved at
the 8 weeks measurement (data not shown). After 4 years,
HbA1c and plasma lipids had significantly improved com-
pared with the baseline and, except for triglycerides, to the
8 weeks measurement. BMI decreased at the 8 weeks
measurement (from 29.5 to 28.3 kg/m2, P<0.01) but was
back at its baseline value at the 4 years measurement.
Diabetes treatment
At the 4 years measurement, 19 of the 106 patients (18%)
were still being treated with lifestyle modification alone, and
for two patients treatment for their diabetes was unknown.
The use of cholesterol-lowering medications increased from
10/144 (7%) at baseline, to 34/106 (32%) at the 4-year fol-
low-up (unknown for two patients). On average, after the first
two visits, patients visited a dietician 0.6 times per year (SD
= 0.9). Seventy-seven per cent of the patients visited a dieti-
cian less than once a year, 13% between one and two times
year, and 10% had two or more consultations.
Discussion
Summary and interpretation of main findings
This study showed that patients in general practice with type
2 diabetes had an unfavourable fat intake at the time that the
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Table 2. Consumption of total energy and fat by patients newly diagnosed with type 2 diabetes compared with reference values for the 
general population of similar age. 
Newly diagnosed patients with type 2 diabetes
Reference values 
Diagnosisa 8 weeksb 4 yearsc for populationd
mean (SD) mean (SD) mean (SD) mean (SD)
Energy intake (MJ/day) 10.6 (3.4) 8.3 (2.2) 8.9 (2.7) 9.1 (2.8)
Total fat (En%) 40.9 (7.3) 35.5 (7.0) 37.7 (7.8) 36.3 (6.7)
Saturated fatty acids (En%) 15.0 (2.8) 12.5 (2.6) 11.9 (3.1) 14.4 (3.4)
Monounsaturated fatty acids (En%) 14.3 (3.0) 11.8 (3.1) 12.8 (3.5) 12.6 (2.9)
Polyunsaturated fatty acids (En%) 9.2 (3.2) 9.3 (3.0) 9.9 (3.9) 6.8 (2.5)
Cholesterol intake (mg/day) 300.8 (123.3) 226.3 (95.2) 201.1 (99.7) 225 (112)
Cholesterol intake (mg/MJ) 28.7 (8.2) 27.5 (8.5) 22.5 (6.0) 25.1 (11.3)
a(n = 144). b(n = 110). c(n = 106). d(n = 2296). En% = % of energy intake; SD = standard deviation.
Table 3. Changes in consumption of total energy and fat by patients newly diagnosed with type 2 diabetes: mean changes from diagnosis
to 8 weeks, from diagnosis to 4 years, and from 8 weeks to 4 years. A negative value indicates a decrease in time.
Change in mean difference Change in mean difference Change in mean difference
diagnosis – 8 weeksa diagnosis – 4 yearsb 8 weeks – 4 yearsc
mean difference (95% CI) mean difference (95% CI) mean difference (95% CI)
Energy intake (MJ/day) -2.2 (-2.6 to -1.7) -1.8 (-2.3 to -1.2) 0.5d (0.09 to 0.9)
Total fat (En%) -5.1 (-6.6 to -3.5) -3.0 (-4.8 to -1.2) 2.5 (1.1 to 3.9)
Saturated fatty acids (En%) -2.4 (-3.0 to -1.8) -3.1 (-3.8 to -2.3) -0.5d (-1.1 to 0.1)
Monounsaturated fatty acids (En%) -2.5 (-3.1 to -1.8) -1.5 (-2.3 to -0.6) 1.0 (0.4 to 1.6)
Polyunsaturated fatty acids (En%) 0.3d (-0.4 to 0.9) 0.9d (0.0 to 1.7) 0.9d (0.0 to 1.8)
Cholesterol intake (mg/day) -63.1 (-77.8 to -48.3) -99.7 (-120.0 to -79.4) -33.6 (-48.3 to -18.8)
Cholesterol intake (mg/MJ) -0.3d (-1.5 to 1.0) -6.2 (-7.8 to -4.6) -5.6 (-7.2 to -4.0)
a(n = 110). b(n = 106). c(n = 86). dAll values except these are significant (P<0.0024).Significance tests are done with an a of 0.0024 (0.05:21) in
order to account for multiple testing. En% = % of energy intake.
diabetes was diagnosed compared with reference values for
the general population. Shortly after the first dietary consul-
tation, fat consumption decreased to levels similar to the
general population. After 4 years, consumption of total fat
had increased again, but was still lower than the baseline
value. This increase was owing to a higher intake of both
poly- and monounsaturated fatty acids. The intake of cho-
lesterol had decreased at the 8 weeks assessment and
decreased further after 4 years. 
The observed changes in the reported fat consumption
may have been owing to several factors. First, ongoing treat-
ment for type 2 diabetes, including education by GPs and
dieticians, may have had a sustained effect on patients’
habits. The patients included in our study received usual
care by their GPs, including initial dietary advice in two con-
sultations, according to the Dutch guidelines on diabetes.
Some patients received more consultations through their
own initiative or on advice from their GP. No further interven-
tions or efforts were made to improve compliance with diet.
Of course, from the data of this observational study we can-
not measure the contribution of specific aspects of diabetes
counselling on the outcomes. But, because we observed
patients who received usual care, we feel that the presented
results should be regarded as the minimally achievable
goals that can be reached regarding fat consumption. 
Second, food habits in the general population are not con-
stant. In the adult general population of The Netherlands,
consumption of total fat had decreased by almost 1% of
energy intake, but saturated fatty acids had increased by
about 1% of energy intake from 1992 to 1998.9 In our study,
the decrease in total fat consumption was more profound
and the consumption of saturated fatty acids decreased.
Therefore, it is not likely that our main results are merely a
reflection of the trend in the general population.
Third, the content of foodstuffs is not constant. Since
‘light’ and low-fat products are currently fashionable, manu-
facturers may tend to change the amount and type of fat in
their products. In theory, it is possible that someone who
does not alter their consumption in terms of foodstuffs will
have a different consumption in terms of nutrients because
the content of the foodstuffs has been changed. We have
not identified studies in the literature to assess the influence
of this potential bias. 
Finally, the method of measuring food habits is a possible
source of bias.15 All available instruments to measure food
intake are subject to recall bias and, therefore, a real gold
standard does not exist. We used a semi-quantitative food
frequency questionnaire, whereas the reference figures for
the general population were based on a dietary record
method. The comparison of the data from patients with type
2 diabetes with those from the general population should,
therefore, be interpreted with caution. 
Strengths and limitations of this study
The main strengths of our study were that it provided follow-
up data (a) of sufficient length, (b) in a cohort of newly diag-
nosed patients with type 2 diabetes (data that provides
knowledge of what happens during a patients’ ‘career’ is
important because it is helpful for formulating feasible treat-
ment goals), (c) with a good long-term participation rate
(74%), and (d) that were rooted in general practice. In The
Netherlands, as in the UK, approximately 75% of patients
with type 2 diabetes are treated by their GP.
One of the drawbacks of our study was that a relatively
high number of patients did not complete the food frequency
questionnaire at the 8 weeks measurement: this was partly
owing to loss of motivation in the patients and the GPs. For
the 4-year follow-up, 20 of these 34 patients could be
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Table 4. Proportion of patients newly diagnosed with type 2 diabetes at diagnosis, after 8 weeks, and after 4 years, that meet 
recommendations for the consumption of fat.
Newly diagnosed patients with type 2 diabetes
Recommended
At diagnosisa 8 weeks after 4 years after consumption
(%) diagnosisb (%) diagnosisc (%) of fatd
Total fat 
£30 En% 8.3 21.8 17.0 <30 En%
£35 En% 21.5 45.5 37.7
Saturated fatty acids 
£7 En%e 0.7 2.7 9.4
£10 En% 7.6 20.9 27.4 <10 En%
£12 En% 15.3 50.0 57.5
Polyunsaturated fatty acids 
<9 En% 41.7 39.1 40.6
9–11 En% 36.1 39.1 30.2 ~10 En%
>11 En% 22.2 21.8 29.2
Monounsaturated fatty acids 
<9 En% 2.8 11.8 13.2
9–11 En% 12.5 38.2 25.5 NSR
>11 En% 84.7 50.0 61.3
Cholesterol 
£200 mg/daye 16.0 47.3 54.7
£300 mg/day 60.4 84.5 93.4 <300 mg/day
a(n = 144). b(n = 110). c(n = 106). dAmerican Diabetes Association, 2002.1 ePatients with LDL ³2.6 mmol/l may benefit from saturated fatty acids
£7% of energy intake and a cholesterol £200 mg/day. En% = % of energy intake; NSR = No specific recommendation.
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included again. The possibility of selective drop out was
examined by comparing essential characteristics of patients
with missing data at short-term and 4-year follow-up. No
significant differences were observed, thus attrition bias was
less probable. Furthermore, this study lacked a control
group. We emphasise that this study was not meant as an
intervention study but as a long-term study to assess the
changes under usual care. The referral to a dietician is in
concordance with the Dutch guidelines. After the first
8 weeks from diagnosis, patients were not given extra care
regarding their lifestyle. Thus, using diabetic patients as a
control group would have been unethical because, in our
view, we would have deliberately undertreated them. Age-
matched healthy volunteers as controls would have been
helpful to estimate the secular trend for fat consumption.
Comparison with existing literature
To our knowledge, only one previous study has assessed fat
consumption in newly diagnosed patients with type 2 diabetes
at diagnosis and after several years.3 In a small sample of the
UK prospective diabetes study population (n = 65) half of
the patients complied with recommendations regarding
total energy intake after 3 years of follow-up. The results of
this study cannot easily be compared with the findings in the
present study because the types of fat were not specified.
The overall decrease in total fat consumption was larger in
our study than the UK prospective diabetes study (²3 versus
1% of energy intake, respectively). The differences between
men and women that were found in the UK population could
not be confirmed in our study. 
Implications for future research and policy
The results regarding the percentage of patients that met
with recommendations might be of particular interest in the
development of future guidelines and treatment targets. The
most important treatment targets were those for saturated
fatty acids and cholesterol consumption (<10% of energy
intake and <300 mg/day, respectively, and for patients with
LDL cholesterol ³2.6 mmol/l, which was the case for most
patients in this study at diagnosis, <7% of energy intake and
<200 mg/day, respectively). Only 27% of patients con-
sumed less than 10% of saturated fatty acids measured as
% of energy intake, and only 9% of the patients consumed
less than 7% of their energy intake by way of saturated fatty
acids. In contrast to this disappointing result, 93%
(<300 mg/day) and 55% (<200 mg/day) of patients met the
target for cholesterol intake. Therefore, the target for the
consumption of cholesterol seems to be realistic and attain-
able for this general practice population, whereas the target
for the consumption of saturated fatty acids is not.
This study reports patients’ food habits in terms of nutrients.
We realise that in normal daily life, patients and doctors do
not talk about mono- or polyunsaturated fatty acids but
about the food itself (for example, french fries, eggs, and
tomatoes) instead. Future research should investigate what
alterations in the choice of foods are more likely to be sus-
tained. Furthermore, a better understanding of the charac-
teristics of patients who have very good or very bad compli-
ance with dietary advice might contribute to more effective
dietary intervention strategies.
This study could help to remove some of the scepticism
that doctors have about the feasibility of initiating and main-
taining more favourable dietary habits in patients with type 2
diabetes. However, the very strict treatment targets for the
consumption of saturated fatty acids and total fat are not
very realistic. To optimise the dietary treatment of type 2 dia-
betes, further lasting care for diet and lifestyle are important,
but also a reconsideration of treatment targets for dietary
fats in diabetic patients remains necessary.
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